TEVA 2050 TEVA 2050 Pill - green capsule-shape
Pill with imprint TEVA 2050 TEVA 2050 is Green, Capsule-shape and has been identified as Tolterodine Tartrate Extended-Release 2 mg. It is supplied by Teva Pharmaceuticals USA Inc.
Tolterodine is used in the treatment of Urinary Frequency; Urinary Incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Tolterodine 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEVA 2050 TEVA 2050
Tolterodine Tartrate Extended-Release
- Imprint
- TEVA 2050 TEVA 2050
- Strength
- 2 mg
- Color
- Green
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Urinary antispasmodics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc.
- National Drug Code (NDC)
- 00093-2050 (Discontinued)
More about tolterodine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (73)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: urinary antispasmodics
- Breastfeeding
- En español
Patient resources
- Tolterodine drug information
- Tolterodine (Advanced Reading)
- Tolterodine Tablets
- Tolterodine Extended-Release Capsules
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.